Compare SVRA & VMET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SVRA | VMET |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.1B |
| IPO Year | 2009 | N/A |
| Metric | SVRA | VMET |
|---|---|---|
| Price | $5.15 | N/A |
| Analyst Decision | Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $7.33 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | N/A |
| Earning Date | 01-01-0001 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.89 | N/A |
| 52 Week High | $7.01 | N/A |
| Indicator | SVRA | VMET |
|---|---|---|
| Relative Strength Index (RSI) | 39.22 | N/A |
| Support Level | $5.10 | N/A |
| Resistance Level | $6.10 | N/A |
| Average True Range (ATR) | 0.29 | 0.00 |
| MACD | -0.05 | 0.00 |
| Stochastic Oscillator | 0.98 | 0.00 |
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.